Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial

WU Ying; CHEN Ji-yan

doi:10.3969/j.issn.1671-5144.2014.06.008

WU Ying, CHEN Ji-yan. Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial[J]. Journal of Evidence-Based Medicine, 2014, 14(6): 339-341. DOI: 10.3969/j.issn.1671-5144.2014.06.008

Citation:

WU Ying, CHEN Ji-yan. Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial[J]. Journal of Evidence-Based Medicine, 2014, 14(6): 339-341. DOI: 10.3969/j.issn.1671-5144.2014.06.008

Citation:

WU Ying, CHEN Ji-yan. Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial[J]. Journal of Evidence-Based Medicine, 2014, 14(6): 339-341. DOI: 10.3969/j.issn.1671-5144.2014.06.008

Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (10)

Lowdose Spironolactone Reduces Blood Pressure in Patients with Resistant Hypertension and Type 2 Diabetes Mellitus: A Double Blind Randomized Clinical Trial

Graphical Abstract

Catalog

Export File

Citation

Format

Content